CV-MG01 (Myasterix)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CV-MG01 (Myasterix), covering 2018-05-30 to 2018-05-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy of CV-MG01 (Myasterix) in Myasthenia Gravis [Phase 2, Phase 3]